- $26.02bn
- $37.69bn
- $29.06bn
- 80
- 84
- 21
- 65
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20,084 | 20,908 | 27,712 | 37,884 | 29,056 |
Cost of Revenue | |||||
Gross Profit | 5,312 | 5,153 | 9,068 | 14,515 | 8,195 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18,222 | 20,025 | 23,073 | 27,075 | 26,311 |
Operating Profit | 1,862 | 883 | 4,639 | 10,809 | 2,745 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,308 | 382 | 4,168 | 10,246 | 1,952 |
Provision for Income Taxes | |||||
Net Income After Taxes | 992 | 459 | 3,179 | 7,687 | 1,282 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 992 | 459 | 3,153 | 7,660 | 1,258 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 992 | 459 | 3,153 | 7,660 | 1,258 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.98 | 1.61 | 5.87 | 13.2 | 3.94 |
Dividends per Share |